Godrej Agrovet (GODREJAGRO)₹591.55−3.37%Animal Feed
In the Jun 2026 quarter (consolidated), Godrej Agrovet reported sales of ₹2,865 Cr, up 9.2% from Jun 2025, and net profit of ₹128 Cr, down 14.1% year on year. For the year to Mar 2026, sales were ₹10,259 Cr and net profit ₹443 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,579 | 2,352 | 2,142 | 2,359 | 2,455 | 2,457 | 2,138 | 2,623 | 2,575 | 2,727 | 2,339 | 2,865 |
| Expenses | 2,375 | 2,190 | 1,992 | 2,131 | 2,231 | 2,234 | 1,992 | 2,349 | 2,361 | 2,482 | 2,198 | 2,620 |
| Operating Profit | 200 | 158 | 148 | 226 | 222 | 219 | 147 | 269 | 212 | 242 | 139 | 239 |
| OPM % | 8.0% | 7.0% | 7.0% | 10.1% | 9.0% | 9.0% | 7.0% | 10.0% | 8.0% | 9.1% | 6.0% | 8.1% |
| Other Income | 19.98 | 20.96 | 19.99 | 24.97 | 24.98 | 21.96 | 24.96 | 23.96 | 17.97 | −4.99 | 77.86 | 26.99 |
| Interest | 27.93 | 24.96 | 24.93 | 29.91 | 39.92 | 33.93 | 28.94 | 34.88 | 39.88 | 34.93 | 28.92 | 29.94 |
| Depreciation | 52.80 | 52.82 | 55.83 | 54.81 | 57.83 | 56.86 | 55.85 | 57.79 | 56.79 | 55.86 | 57.81 | 56.85 |
| Profit before tax | 141 | 102 | 87.22 | 167 | 150 | 151 | 87.26 | 201 | 135 | 146 | 130 | 181 |
| Tax % | 26.0% | 19.0% | 25.0% | 21.0% | 36.0% | 27.0% | 24.0% | 26.0% | 38.0% | 25.0% | 21.0% | 29.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −21.92 | 0.00 | 0.00 |
| Net Profit | 104 | 82.68 | 64.79 | 131 | 95.76 | 110 | 65.78 | 148 | 83.68 | 110 | 102 | 128 |
| EPS (Rs) | 5.49 | 4.79 | 2.98 | 7.04 | 5.85 | 5.81 | 3.69 | 8.36 | 4.82 | 5.98 | 5.46 | 7.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,763 | 4,923 | 5,204 | 5,932 | 6,988 | 6,286 | 8,331 | 9,407 | 9,596 | 9,403 | 10,259 | 10,506 |
| Expenses | 3,586 | 4,479 | 4,752 | 5,474 | 6,493 | 5,720 | 7,657 | 8,868 | 8,883 | 8,585 | 9,387 | 9,662 |
| Operating Profit | 171 | 439 | 444 | 454 | 488 | 562 | 667 | 522 | 703 | 819 | 862 | 832 |
| OPM % | 4.6% | 9.0% | 9.0% | 8.0% | 7.1% | 9.0% | 8.1% | 6.0% | 7.0% | 9.1% | 8.0% | 7.9% |
| Other Income | 315 | 94.91 | 57.91 | 154 | 48.95 | 89.92 | 109 | 139 | 89.95 | 92.86 | 116 | 118 |
| Interest | 97.71 | 85.82 | 44.91 | 33.92 | 41.91 | 45.91 | 62.85 | 98.80 | 108 | 133 | 138 | 134 |
| Depreciation | 51.80 | 74.78 | 85.66 | 97.73 | 147 | 153 | 172 | 185 | 213 | 225 | 228 | 227 |
| Profit before tax | 337 | 376 | 373 | 478 | 350 | 454 | 543 | 379 | 474 | 556 | 614 | 594 |
| Tax % | 22.0% | 27.0% | 32.0% | 27.0% | 14.0% | 23.0% | 23.0% | 22.0% | 24.0% | 27.0% | 27.0% | — |
| Exceptional items | 96.67 | 32.87 | 6.98 | 82.77 | −6.98 | 0.00 | −14.94 | 53.84 | −1.99 | −2.99 | 11.96 | −21.92 |
| Net Profit | 260 | 272 | 250 | 348 | 300 | 347 | 418 | 294 | 358 | 402 | 443 | 422 |
| EPS (Rs) | 28.22 | 13.45 | 11.96 | 17.15 | 15.95 | 16.35 | 20.97 | 15.72 | 18.74 | 22.39 | 24.60 | 23.26 |
| Dividend payout % | 16.1% | 33.1% | 38.0% | 26.0% | 34.1% | 49.1% | 45.1% | 60.1% | 53.1% | 49.1% | 45.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 92.96 | 92.97 | 185 | 192 | 192 | 192 | 192 | 192 | 192 | 192 | 192 | 192 |
| Reserves | 548 | 689 | 824 | 1,218 | 1,456 | 1,646 | 1,858 | 2,075 | 2,145 | 2,323 | 2,187 | 1,838 |
| Borrowings | 684 | 1,370 | 663 | 409 | 397 | 651 | 1,006 | 1,598 | 1,432 | 1,414 | 1,396 | 1,574 |
| Other Liabilities | 419 | 961 | 1,537 | 1,716 | 2,186 | 2,185 | 1,727 | 1,692 | 1,677 | 1,741 | 1,735 | 2,558 |
| Total Liabilities | 1,742 | 3,112 | 3,209 | 3,535 | 4,231 | 4,673 | 4,783 | 5,557 | 5,446 | 5,671 | 5,508 | 6,162 |
| Fixed Assets | 695 | 1,512 | 1,478 | 1,497 | 2,057 | 2,184 | 2,306 | 2,414 | 2,574 | 2,815 | 2,921 | 2,811 |
| CWIP | 138 | 63.89 | 49.90 | 190 | 93.83 | 153 | 141 | 89.83 | 204 | 192 | 63.93 | 201 |
| Investments | 36.93 | 58.94 | 175 | 195 | 117 | 129 | 124 | 160 | 158 | 177 | 139 | 115 |
| Other Assets | 872 | 1,478 | 1,506 | 1,653 | 1,964 | 2,206 | 2,213 | 2,895 | 2,509 | 2,488 | 2,385 | 3,036 |
| Inventories | 389 | 667 | 738 | 763 | 899 | 885 | 979 | 1,427 | 1,342 | 1,381 | 1,258 | 1,358 |
| Trade receivables | 269 | 455 | 522 | 620 | 734 | 853 | 823 | 950 | 574 | 518 | 571 | 672 |
| Cash & equivalents | 16.96 | 41.90 | 61.87 | 31.94 | 29.93 | 50.89 | 50.90 | 34.92 | 29.92 | 52.85 | 38.91 | 301 |
| Total Assets | 1,742 | 3,112 | 3,209 | 3,535 | 4,231 | 4,673 | 4,783 | 5,557 | 5,446 | 5,671 | 5,508 | 6,162 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 109 | 168 | 897 | 354 | 448 | 240 | −2.01 | −120 | 875 | 679 | 970 | 1,281 |
| Cash from investing activity | −131 | −429 | −63.08 | −253 | −233 | −255 | −187 | −208 | −284 | −328 | −82.12 | −150 |
| Cash from financing activity | −79.32 | 279 | −816 | −125 | −218 | 36.16 | 190 | 312 | −597 | −329 | −904 | −872 |
| Net cash flow | −101 | 17.94 | 21.91 | −23.92 | −1.99 | 20.92 | 0.00 | −16.94 | −4.98 | 22.92 | −12.94 | 261 |
| Capex | 112 | 133 | 205 | 246 | 276 | 263 | 256 | 271 | 358 | 383 | 225 | 296 |
| Free cash flow | −0.99 | 42.97 | 701 | 109 | 207 | −17.99 | −251 | −388 | 595 | 301 | 758 | 1,046 |
| CFO / OP % | 61.0% | 125.0% | 222.0% | 98.0% | 122.0% | 69.0% | 20.0% | 5.0% | 185.0% | 114.0% | 136.0% | 167.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 31 | 45 | 40 | 45 | 46 | 46 | 49 | 43 | 23 | 21 | 23 | 25 |
| Inventory days | 55 | 84 | 72 | 71 | 73 | 61 | 79 | 84 | 67 | 71 | 67 | 66 |
| Days payable | 31 | 43 | 82 | 83 | 100 | 88 | 59 | 41 | 36 | 33 | 48 | 81 |
| Cash conversion cycle | 55 | 86 | 30 | 32 | 19 | 18 | 69 | 85 | 55 | 59 | 43 | 11 |
| Working capital days | 48 | −52 | −27 | −9 | −4 | −8 | 6 | 5 | −5 | 0 | −3 | −18 |
| ROCE % | 24.0% | 17.0% | 19.0% | 20.0% | 18.0% | 15.0% | 16.0% | 16.0% | 10.0% | 14.0% | 17.0% | 19.0% |
For the Jun 2026 quarter, Godrej Agrovet reported sales of ₹2,865 Cr, up 9.2% year on year and net profit of ₹128 Cr, down 14.1% year on year. The operating margin was 8.1%.
Godrej Agrovet's sales for the year to Mar 2026 were ₹10,259 Cr; over the last twelve months they were ₹10,506 Cr.
Net profit for the year to Mar 2026 was ₹443 Cr, and ₹422 Cr over the last twelve months. Earnings per share over the same trailing period were ₹23.26.
Godrej Agrovet reported borrowings of ₹1,574 Cr at Mar 2026, against cash and equivalents of ₹301 Cr.
Cash from operations was ₹1,281 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1,046 Cr.